Market Research Logo

XOMA Corporation (XOMA) - Financial and Strategic SWOT Analysis Review

XOMA Corporation (XOMA) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

XOMA Corporation (Xoma), formerly Xoma Ltd., is a biopharmaceutical company that discovers, develops antibody-based therapeutics. Its lead product, gevokizumab is a monoclonal antibody used for the treatment a wide variety of inflammatory diseases and other diseases. Its other pipeline products include XMet, XOMA 3AB, HCD122, FDC1 and LFA102. XMet is used for the potential treatment of diabetes and other metabolic syndromes; XOMA 3AB is used to neutralize the botulinum toxin; HCD122 and LFA102 are in development for the treatment of prostate or breast cancer; FDC1 is used for the treatment of hypertension. Xoma has developed its proprietary antibody discovery, optimization and development technologies, comprising ADAPT, ModulX and OptimX. It operates through its subsidiaries in Bermuda, Ireland, and the US. Xoma is headquartered in Berkeley, California, the US.

XOMA Corporation Key Recent Developments


Aug 03, 2016: XOMA Reports Second Quarter 2016 Achievements and Financial Results
May 04, 2016: XOMA Reports First Quarter 2016 Operational Achievements and Financial Results
Mar 09, 2016: XOMA Reports Fourth Quarter and Full-Year 2015 Financial Results
Nov 05, 2015: XOMA Provides Corporate Update and Reports Financial Results for Third Quarter 2015
Aug 06, 2015: XOMA Reports Financial Results for Second Quarter 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
XOMA Corporation - Key Facts
XOMA Corporation - Key Employees
XOMA Corporation - Key Employee Biographies
XOMA Corporation - Major Products and Services
XOMA Corporation - Pharmaceutical Pipeline Products Data
XOMA Corporation, Pipeline Products by Therapy Area
XOMA Corporation, Pipeline Products by Development Phase
XOMA Corporation - History
XOMA Corporation - Company Statement
XOMA Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
XOMA Corporation - Business Description
XOMA Corporation - Corporate Strategy
XOMA Corporation - SWOT Analysis
SWOT Analysis - Overview
XOMA Corporation - Strengths
XOMA Corporation - Weaknesses
XOMA Corporation - Opportunities
XOMA Corporation - Threats
XOMA Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
XOMA Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
XOMA Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
XOMA Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 03, 2016: XOMA Reports Second Quarter 2016 Achievements and Financial Results
May 04, 2016: XOMA Reports First Quarter 2016 Operational Achievements and Financial Results
Mar 09, 2016: XOMA Reports Fourth Quarter and Full-Year 2015 Financial Results
Nov 05, 2015: XOMA Provides Corporate Update and Reports Financial Results for Third Quarter 2015
Aug 06, 2015: XOMA Reports Financial Results for Second Quarter 2015
May 07, 2015: XOMA Reports First Quarter 2015 Achievements and Financial Results
Mar 11, 2015: XOMA Highlights Recent Achievements and Reports Fourth Quarter and Full-Year 2014 Financial Results
Mar 03, 2015: XOMA Announces Retirement of Fred Kurland and Appointment of Thomas Burns as Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
XOMA Corporation, Key Facts
XOMA Corporation, Key Employees
XOMA Corporation, Key Employee Biographies
XOMA Corporation, Major Products and Services
XOMA Corporation, Number of Pipeline Products by Therapy Area
XOMA Corporation, Number of Pipeline Products by Development Stage
XOMA Corporation, Pipeline Products By Therapy Area and Development Phase
XOMA Corporation, History
XOMA Corporation, Subsidiaries
XOMA Corporation, Key Competitors
XOMA Corporation, Ratios based on current share price
XOMA Corporation, Annual Ratios
XOMA Corporation, Interim Ratios
XOMA Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
XOMA Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
XOMA Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
XOMA Corporation, Pipeline Products by Therapy Area
XOMA Corporation, Pipeline Products by Development Phase
XOMA Corporation, Performance Chart (2011 - 2015)
XOMA Corporation, Ratio Charts
XOMA Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
XOMA Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report